Table 2.
t-test | |||
---|---|---|---|
UNa (μmol min-1) | |||
HS | Patients | 203 (179; 227)§ | P = 0.215 |
Controls | 226 (195; 257)§ | ||
LS | Patients | 42 (31; 53) | P = 0.494 |
Controls | 47 (35; 59) | ||
u-EnaCβ-CR (pg μmol-1) | |||
HS | Patients | 14.33 (12.30; 16.37) | P = 0.980 |
Controls | 14.37 (12.34; 16.40) | ||
LS | Patients | 12.54 (11.35; 13.74) | P = 0.084 |
Controls | 14.19 (13.00; 15.38) | ||
V (ml min-1) | |||
HS | Patients | 2702 (2331; 3074) | P = 0.628 |
Controls | 2828 (2442; 3213) | ||
LS | Patients | 2991 (2721; 3260) | P = 0.207 |
Controls | 2715 (2353; 3078) | ||
u-AQP2CR (ng mmol-1) | |||
HS | Patients | 143 (117; 168)§ | P = 0.781 |
Controls | 147 (129; 165)§ | ||
LS | Patients | 101 (89; 114) | P = 0.192 |
Controls | 112 (101; 122) | ||
u-osm (mOsm kg-1) | |||
HS | Patients | 405 (363; 447)§ | P = 0.409 |
Controls | 436 (372; 499)§ | ||
LS | Patients | 221 (204; 238) | P = 0.026 |
Controls | 306 (231; 381) |
Values are means with 95% confidence intervals in brackets. UNa, urinary sodium excretion rate; u-ENaCβ-CR, urinary ENaCβ excretion corrected for creatinine; V, urinary flow; u-AQP2CR, urinary AQP2 excretion corrected for creatinine; u-osm, urine osmolality; t-test: patients compared with controls, Student's t-test. § P < 0.001, HS vs. LS intake, paired samples t-test.